semaglutide blue cross Blue Shield of Michigan won't cover popular weight-loss drugs Why Blue Cross Blue Shield

It works by mimicking a hormone that regulates appetite and food intake, leading to improved blood sugar control and often significant weight loss

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for three primary indications: type 2 diabetes mellitus, chronic weight management, and cardiovascular risk reduction in adults with obesity/overweight and established cardiovascular disease

a meta-analysis of longitudinal studies

*Correspondence: Yue Chen, [email protected] These authors have contributed equally to this work and share first authorship Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Its a physiological state where the body senses that it has consumed enough food